Review
Open access
Jul 2026
Antibody–Drug Conjugates Targeting HER2 and Trop-2: A New Force in Precision Treatment for Solid Tumors
Key clinical data and application prospects in breast cancer, gastric cancer, non-small cell lung cancer, and urothelial carcinoma are summarized and analyzed, while also delving into the challenges and future directions within this field.
Zhaoling Jiang, Chen Mei, Xueze Lyu et al.
· Pharmaceuticals · 0 citations